HCA Midwest Health July 12, 2017

HCA Midwest Health, Kansas City’s leading healthcare provider that offers metro residents more than 150 access points to convenient, top-quality healthcare—including the acclaimed Sarah Cannon Caner Institute at HCA Midwest Health—recently participated in the 2017 PurpleStride Kansas City at Theis Park. Over the years, HCA Midwest Health and its family of hospitals has supported the effort to help end the nation’s deadliest major cancer that has a five-year survival rate of just nine percent. The Pancreatic Cancer Action Network (PanCAN) has an urgent mission to improve outcomes for patients currently battling the disease and to double pancreatic cancer survival by 2020.

Each year, more than 80,000 people in cities across the U.S. participate in PurpleStride. Funds raised through this signature event support the organization’s key initiatives, including Precision Promise, Know Your TumorSM and the Patient Registry.  

Joseph Cates, M.D., board certified vascular surgeon at Overland Park Regional Medical Center and Jaswinder Singh, M.D., board certified medical oncologist and Clinical Research Director of Sarah Cannon HCA Midwest Health, attended the walk with 11 patients who are pancreatic cancer survivors.

“This was a significant walk for us to participate in,” says Dr. Cates. “We helped raise money to support what the Pancreatic Cancer Action Network does, like funding research and other critical programs and services for patients and their families and helping to change outcomes for patients facing the disease today and those who will face it tomorrow, both here in Kansas City and beyond.”

“We do important work here in Kansas City at Sarah Cannon Cancer Institute at HCA Midwest Health to help end pancreatic cancer,” says Dr. Singh. “The underlying message of the PurpleStride walk is ‘Wage Hope,’ and we, along with our researchers and teams of physicians, do just that everyday. Walking with pancreatic survivors sends a powerful message.”

HCA Midwest Health provides comprehensive care and advanced treatments for cancers of all types, including pancreatic cancer, and partners with the Sarah Cannon Cancer Institute, the cancer service line of HCA, and a leader in world-class cancer care.

The Sarah Cannon Cancer Institute at HCA Midwest Health is a cancer network anchored by four accredited HCA Midwest Health hospitals— Belton Regional Medical Center, Centerpoint Medical Center, Menorah Medical Center and Research Medical Center—and is complemented by numerous cancer care outreach sites located in communities throughout metropolitan Kansas City and the surrounding areas.

For more information on HCA Midwest Health’s spectrum of acclaimed cancer services, visit http://hcamidwest.com/service/cancer-care.